Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal cell wall is a complex and dynamic extracellular matrix essential for the survival, structural integrity, and virulence of fungal pathogens. It is primarily composed of a core scaffold of polysaccharides, including chitin and beta-glucans, which are covalently linked to an outer layer of cell wall proteins (CWPs). These proteins, many of which are glycosylphosphatidylinositol (GPI)-anchored, are critical for maintaining the mechanical strength of the wall, mediating adhesion to host tissues, and facilitating the formation of biofilms. The structural protein–polysaccharide interfaces represent the specific covalent bonds and molecular interactions that integrate these proteins into the polysaccharide matrix. Disruption of these interfaces, particularly through the inhibition of enzymes like Gwt1 (an inositol acyltransferase involved in GPI anchor biosynthesis), has emerged as a potent antifungal strategy. Drugs such as fosmanogepix (and its active moiety manogepix) target this process, leading to the loss of cell wall proteins, compromised wall integrity, and reduced pathogenicity, making them promising candidates for treating invasive fungal infections.
Inhibition of Gwt1 (inositol acyltransferase), which prevents the maturation and localization of GPI-anchored cell wall proteins.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal pathogen cell wall proteins and structural protein–polysaccharide interfaces.